7827 — HanchorBio Cashflow Statement
0.000.00%
Last trade - 00:00- TWD22.34bn
- TWD21.73bn
- TWD312.22m
Annual cashflow statement for HanchorBio, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -446 | -591 | -1,354 | -369 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | -44.2 | 104 | 709 | 2.9 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 126 | 13.6 | 1.23 | 9.72 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -338 | -440 | -607 | -318 |
| Capital Expenditures | -70.8 | -23.2 | -19 | -18.7 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 1.13 | -87.7 | 76.4 | 13.6 |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -69.6 | -111 | 57.4 | -5.18 |
| Financing Cash Flow Items | — | -0.1 | — | 296 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 500 | 645 | 605 | 951 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 105 | 95.8 | 63.6 | 659 |